Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berry

Showing results (1051-1060 of 1,114) with videos related to

Pageof 112
Sort By:
Vaccines|June 24, 2022
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 VirusesRamireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Toxicology|September 19, 2016
Upholding science in health, safety and environmental risk assessments and regulationsMichael Aschner, Herman N Autrup, Sir Colin L Berry, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Ophthalmology|March 21, 2025
Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma: A Multicenter Study of 1203 ProceduresDouglas Chigane, Drishti Pandya, Muskaan Singh, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Urologic Oncology|May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotypingDana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
Eye (London, England)|July 17, 2021
Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countriesIdo Didi Fabian, Vikas Khetan, Andrew W Stacey, et al.
JAMA Ophthalmology|November 11, 2021
Defining High-risk Retinoblastoma: A Multicenter Global SurveySwathi Kaliki, Carol L Shields, Nathalie Cassoux, et al.
Retina (Philadelphia, Pa.)|December 2, 2024
NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDYGuy S Negretti, Tatiana Ushakova, Serov Yuri, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Pageof 112

Showing results (1051-1060 of 1,114) with videos related to

Sort By:
Pageof 112
Vaccines|June 24, 2022
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 VirusesRamireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Toxicology|September 19, 2016
Upholding science in health, safety and environmental risk assessments and regulationsMichael Aschner, Herman N Autrup, Sir Colin L Berry, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Ophthalmology|March 21, 2025
Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma: A Multicenter Study of 1203 ProceduresDouglas Chigane, Drishti Pandya, Muskaan Singh, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Urologic Oncology|May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotypingDana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
Eye (London, England)|July 17, 2021
Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countriesIdo Didi Fabian, Vikas Khetan, Andrew W Stacey, et al.
JAMA Ophthalmology|November 11, 2021
Defining High-risk Retinoblastoma: A Multicenter Global SurveySwathi Kaliki, Carol L Shields, Nathalie Cassoux, et al.
Retina (Philadelphia, Pa.)|December 2, 2024
NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDYGuy S Negretti, Tatiana Ushakova, Serov Yuri, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Pageof 112